157 related articles for article (PubMed ID: 20659515)
1. Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience.
Hajjeh RA; Privor-Dumm L; Edmond K; O'Loughlin R; Shetty S; Griffiths UK; Bear AP; Cohen AL; Chandran A; Schuchat A; Mulholland EK; Santosham M
Vaccine; 2010 Oct; 28(43):7123-9. PubMed ID: 20659515
[TBL] [Abstract][Full Text] [Related]
2. Global use of Haemophilus influenzae type b conjugate vaccine.
Ojo LR; O'Loughlin RE; Cohen AL; Loo JD; Edmond KM; Shetty SS; Bear AP; Privor-Dumm L; Griffiths UK; Hajjeh R
Vaccine; 2010 Oct; 28(43):7117-22. PubMed ID: 20691265
[TBL] [Abstract][Full Text] [Related]
3. Progress toward introduction of Haemophilus influenzae type b vaccine in low-income countries--worldwide, 2004-2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(6):148-51. PubMed ID: 18272957
[TBL] [Abstract][Full Text] [Related]
4. Accelerating introduction of new vaccines: barriers to introduction and lessons learned from the recent Haemophilus influenzae type B vaccine experience.
Hajjeh R
Philos Trans R Soc Lond B Biol Sci; 2011 Oct; 366(1579):2827-32. PubMed ID: 21893547
[TBL] [Abstract][Full Text] [Related]
5. The impact of vaccines on pneumonia: key lessons from Haemophilus influenzae type b conjugate vaccines.
Gessner BD; Adegbola RA
Vaccine; 2008 Jun; 26 Suppl 2():B3-8. PubMed ID: 18793604
[TBL] [Abstract][Full Text] [Related]
6. Foresight in medicine: current challenges with Haemophilus influenzae type b conjugate vaccines.
Eskola J
J Intern Med; 2010 Mar; 267(3):241-50. PubMed ID: 20201918
[TBL] [Abstract][Full Text] [Related]
7. NTAGI subcommittee recommendations on Haemophilus influenzae type B (Hib) vaccine introduction in India.
Subcommittee on Introduction of Hib Vaccine in Universal Immunization Program, National Technical Advisory Group on Immunization, India
Indian Pediatr; 2009 Nov; 46(11):945-54. PubMed ID: 19955578
[TBL] [Abstract][Full Text] [Related]
8. Introducing new vaccines in developing countries: concepts and approaches to estimating burden of Haemophilus influenzae type b-associated disease.
Kilgore PE; Nyambat B
J Health Popul Nutr; 2004 Sep; 22(3):246-56. PubMed ID: 15609777
[TBL] [Abstract][Full Text] [Related]
9. Haemophilus influenzae type b conjugate vaccine use and effectiveness.
Morris SK; Moss WJ; Halsey N
Lancet Infect Dis; 2008 Jul; 8(7):435-43. PubMed ID: 18582836
[TBL] [Abstract][Full Text] [Related]
10. Lessons learned during the development and transfer of technology related to a new Hib conjugate vaccine to emerging vaccine manufacturers.
Hamidi A; Boog C; Jadhav S; Kreeftenberg H
Vaccine; 2014 Jul; 32(33):4124-30. PubMed ID: 24923635
[TBL] [Abstract][Full Text] [Related]
11. Implications of private sector Hib vaccine coverage for the introduction of public sector Hib-containing pentavalent vaccine in India: evidence from retrospective time series data.
Sharma A; Kaplan WA; Chokshi M; Hasan Farooqui H; Zodpey SP
BMJ Open; 2015 Feb; 5(2):e007038. PubMed ID: 25712822
[TBL] [Abstract][Full Text] [Related]
12. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?
Lydon P; Levine R; Makinen M; Brenzel L; Mitchell V; Milstien JB; Kamara L; Landry S
Vaccine; 2008 Dec; 26(51):6706-16. PubMed ID: 18952134
[TBL] [Abstract][Full Text] [Related]
13. Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination.
Adam HJ; Richardson SE; Jamieson FB; Rawte P; Low DE; Fisman DN
Vaccine; 2010 May; 28(24):4073-8. PubMed ID: 20398617
[TBL] [Abstract][Full Text] [Related]
14. Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic.
Marshall H; McIntyre P; Roberton D; Dinan L; Hardt K
Int J Infect Dis; 2010 Jan; 14(1):e41-9. PubMed ID: 19467896
[TBL] [Abstract][Full Text] [Related]
15. Forecasting demand for Hib-containing vaccine in the world's poorest countries: a 4-year prospective experience.
Zuber PL; Dumolard L; Shirey M; Rizzo I; Marshall J
Vaccine; 2009 Jan; 27(3):410-5. PubMed ID: 19013493
[TBL] [Abstract][Full Text] [Related]
16. Ongoing control of Haemophilus influenzae type B infections in Canadian children, 2004-2007.
Scheifele DW; Bettinger JA; Halperin SA; Law B; Bortolussi R
Pediatr Infect Dis J; 2008 Aug; 27(8):755-7. PubMed ID: 18594482
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
[TBL] [Abstract][Full Text] [Related]
18. Hib returns.
Edwards A
Minn Med; 2009 Mar; 92(3):35-6. PubMed ID: 19400384
[No Abstract] [Full Text] [Related]
19. Lessons learned from the 2007 to 2009 Haemophilus influenzae type B vaccine shortage: implications for future vaccine shortages and public health preparedness.
Chamberlain AT; Wells K; Seib K; Kudis A; Hannan C; Orenstein WA; Whitney EA; Hinman AR; Buehler JW; Omer SB; Berkelman RL
J Public Health Manag Pract; 2012; 18(3):E9-E16. PubMed ID: 22473128
[TBL] [Abstract][Full Text] [Related]
20. Worldwide introduction and coverage of Haemophilus influenzae type b conjugate vaccine.
O'Loughlin R; Hajjeh R;
Lancet Infect Dis; 2008 Dec; 8(12):736. PubMed ID: 19022186
[No Abstract] [Full Text] [Related]
[Next] [New Search]
